Lumexa Imaging (NASDAQ:LMRI) Issues FY 2026 Earnings Guidance

Lumexa Imaging (NASDAQ:LMRI) updated its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.860-0.900 for the period, compared to the consensus EPS estimate of 0.660. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Analysts Set New Price Targets

A number of analysts recently issued reports on LMRI shares. Wall Street Zen upgraded shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Raymond James Financial set a $19.00 price target on Lumexa Imaging and gave the company a “strong-buy” rating in a report on Wednesday. Deutsche Bank set a $16.00 price target on Lumexa Imaging in a research note on Thursday, August 13th. KeyCorp began coverage on Lumexa Imaging in a report on Thursday, September 24th. They set an “overweight” rating and a $18.00 price objective on the stock. Finally, UBS Group restated a “strong-buy” rating on shares of Lumexa Imaging in a report on Wednesday. Two equities research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $16.80.

Lumexa Imaging Price Performance

Shares of LMRI stock opened at $14.94 on Friday. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 1.40. Lumexa Imaging has a 1-year low of $6.45 and a 1-year high of $19.45. The firm’s 50-day simple moving average is $11.39 and its 200-day simple moving average is $11.08.

Lumexa Imaging (NASDAQ:LMRI) last announced its quarterly earnings results on Tuesday, November 10th. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.19. The company had revenue of $271.97 million for the quarter. Lumexa Imaging had a negative net margin of 1.96% and a negative return on equity of 2.93%. As a group, research analysts anticipate that Lumexa Imaging will post 0.25 earnings per share for the current year.

Lumexa Imaging Company Profile

Lumexa Imaging operates outpatient diagnostic imaging centers that provide radiology services to patients, referring physicians and healthcare providers. Its services include imaging used to help diagnose and monitor a range of medical conditions. The company offers diagnostic procedures such as MRI, CT, PET/CT, mammography, ultrasound and X-ray through its imaging centers and affiliated radiology practices. Lumexa serves communities across the United States, providing an outpatient option for medical imaging outside of a hospital setting.